Patents by Inventor Sanjeev Luther

Sanjeev Luther has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • THERAPEUTIC METHODS AND COMPOSITIONS FOR TREATING BILIARY TRACT CANCER USING DEVIMISTAT
    Publication number: 20240115591
    Abstract: The invention provides a method for treating biliary tract cancer in a patient in need thereof, comprising the step of intravenously administering to the patient a therapeutically effective amount of (i) devimistat, (ii) gemcitabine, and (iii) cisplatin, in order to treat the biliary tract cancer.
    Type: Application
    Filed: November 3, 2021
    Publication date: April 11, 2024
    Inventors: Sanjeev Luther, Timothy Pardee, Vaibhav Sahai
  • THERAPEUTIC METHODS AND COMPOSITIONS FOR TREATING PANCREATIC CANCER USING DEVIMISTAT
    Publication number: 20240016805
    Abstract: The invention provides methods, compositions, and medical kits for treating pancreatic cancer using (i) devimistat in combination with (ii) modified FOLFIRINOX.
    Type: Application
    Filed: November 3, 2021
    Publication date: January 18, 2024
    Inventor: Sanjeev Luther
  • Therapeutic methods and compositions for treating pancreatic cancer using 6,8-bis-benzylthio-octanoic acid
    Patent number: 11622950
    Abstract: The invention provides methods, compositions, and medical kits for treating pancreatic cancer using (i) 6,8-bis(benzylsulfanyl)octanoic acid or a pharmaceutically acceptable salt thereof in combination with (ii) gemcitabine or a pharmaceutically acceptable salt thereof, and (iii) nab-paclitaxel.
    Type: Grant
    Filed: July 23, 2019
    Date of Patent: April 11, 2023
    Assignee: Cornerstone Pharmaceuticals, Inc.
    Inventors: Sanjeev Luther, Robert G. L. Shorr
  • THERAPEUTIC METHODS AND COMPOSITIONS FOR TREATING CANCER USING 6,8-BIS-BENZYLTHIO-OCTANOIC ACID AND A GLUTAMINASE INHIBITOR
    Publication number: 20220331279
    Abstract: The invention provides methods and compositions for treating cancer by administering to a patient in need thereof a therapeutically effective amount of 6,8-bis-benzylthio-octanoic acid and a glutaminase inhibitor.
    Type: Application
    Filed: August 14, 2020
    Publication date: October 20, 2022
    Inventor: Sanjeev LUTHER
  • THERAPEUTIC METHODS AND COMPOSITIONS FOR TREATING CANCER USING 6,8-BIS-BENZYLTHIO-OCTANOIC ACID AND AN AUTOPHAGY INHIBITOR
    Publication number: 20220054445
    Abstract: The invention provides methods and compositions for treating cancer by administering to a patient in need thereof a therapeutically effective amount of 6,8-bis-benzylthio-octanoic acid and an autophagy inhibitor.
    Type: Application
    Filed: December 20, 2019
    Publication date: February 24, 2022
    Inventors: Timothy S. Pardee, Sanjeev Luther, Paul Bingham, Zuzana Zachar, Shawn D. Stuart, Robert G.L. Shorr, Tamotsu Takeuchi, Yusuke Kito, Chiemi Saigo
  • THERAPEUTIC METHODS AND COMPOSITIONS FOR TREATING ACUTE MYELOID LEUKEMIA USING DEVIMISTAT
    Publication number: 20210393664
    Abstract: The invention provides methods, compositions, and medical kits for treating acute myeloid leukemia using devimistat in combination with cytarabine and mitoxantrone.
    Type: Application
    Filed: November 27, 2019
    Publication date: December 23, 2021
    Inventors: Sanjeev Luther, Timothy S. Pardee, Jorge Jorge Cortes
  • THERAPEUTIC METHODS AND COMPOSITIONS FOR TREATING PANCREATIC CANCER USING 6,8-BIS-BENZYLTHIO-OCTANOIC ACID
    Publication number: 20210267922
    Abstract: The invention provides methods, compositions, and medical kits for treating pancreatic cancer using (i) 6,8-bis(benzylsulfanyl)octanoic acid or a pharmaceutically acceptable salt thereof in combination with (ii) gemcitabine or a pharmaceutically acceptable salt thereof, and (iii) nab-paclitaxel.
    Type: Application
    Filed: July 23, 2019
    Publication date: September 2, 2021
    Inventors: Sanjeev Luther, Robert G.L. Shorr
  • THERAPEUTIC METHODS AND COMPOSITIONS FOR TREATING PROSTATE CANCER USING 6,8-BIS-BENZYLTHIO-OCTANOIC ACID
    Publication number: 20210000778
    Abstract: The invention provides methods, compositions, and medical kits for treating prostate cancer using 6,8-bis-benzylthio-octanoic acid or a pharmaceutically acceptable salt thereof, including combination therapy with docetaxel.
    Type: Application
    Filed: April 16, 2019
    Publication date: January 7, 2021
    Inventors: Sanjeev Luther, Robert G.L. Shorr, Paul Bingham, Zuzana Zachar